NEURONE-SPECIFIC ENOLASE INCREASED

This adverse event was reported 43 times

These drugs are most commonly taken by patients reporting NEURONE-SPECIFIC ENOLASE INCREASED:

# Drug Count
0 ACETAMINOPHEN 4
1 ACETAMINOPHEN 500MG 3
2 ACETAMINOPHEN TABLET EXTENDED RELEASE 3
3 DOCETAXEL 3
4 DOCETAXEL ANHYDROUS 3
5 PAIN RELIEVER 3
6 AFATINIB 2
7 BEVACIZUMAB 2
8 BUPROPION HYDROCHLORIDE 2
9 DABRAFENIB 2
See all common drugs associated with NEURONE-SPECIFIC ENOLASE INCREASED

NEURONE-SPECIFIC ENOLASE INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CLINDAMYCIN PALMITATE HYDROCHLORIDE 1 0.0044
1 DINUTUXIMAB 1 0.0012
2 VERICIGUAT 1 0.0010
3 SELUMETINIB 1 0.0006
4 ETHAMBUTOL HYDROCHLORIDE 1 0.0004
5 AFATINIB 2 0.0003
6 MANNITOL 1 0.0002
7 DEGARELIX 1 0.0002
8 TELOTRISTAT ETHYL 1 0.0002
9 ERTAPENEM SODIUM 1 0.0001
See all drugs enriched for association with NEURONE-SPECIFIC ENOLASE INCREASED